Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Lowered to $25 at H.C. Wainwright

May 13, 2026 7:48 AM
(Updated - May 13, 2026 7:50 AM EDT)

H.C. Wainwright analyst Mitchell S. Kapoor lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change